This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Aug 7;424(6949):602.

doi: 10.1038/424602a.

Fast vaccine offers hope in battle with Ebola

Tom Clarke, Jonathan Knight

PMID: 12904747
PMCID: PMC7095313
DOI: 10.1038/424602a

Comment

Fast vaccine offers hope in battle with Ebola

Tom Clarke et al. Nature. 2003.

. 2003 Aug 7;424(6949):602.

doi: 10.1038/424602a.

Authors

Tom Clarke, Jonathan Knight

PMID: 12904747
PMCID: PMC7095313
DOI: 10.1038/424602a

No abstract available

PubMed Disclaimer

Comment on

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.
Sullivan NJ, Geisbert TW, Geisbert JB, Xu L, Yang ZY, Roederer M, Koup RA, Jahrling PB, Nabel GJ. Sullivan NJ, et al. Nature. 2003 Aug 7;424(6949):681-4. doi: 10.1038/nature01876. Nature. 2003. PMID: 12904795 Free PMC article.

Similar articles

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.
Sullivan NJ, Geisbert TW, Geisbert JB, Xu L, Yang ZY, Roederer M, Koup RA, Jahrling PB, Nabel GJ. Sullivan NJ, et al. Nature. 2003 Aug 7;424(6949):681-4. doi: 10.1038/nature01876. Nature. 2003. PMID: 12904795 Free PMC article.
Evaluation in nonhuman primates of vaccines against Ebola virus.
Geisbert TW, Pushko P, Anderson K, Smith J, Davis KJ, Jahrling PB. Geisbert TW, et al. Emerg Infect Dis. 2002 May;8(5):503-7. doi: 10.3201/eid0805.010284. Emerg Infect Dis. 2002. PMID: 11996686 Free PMC article.
Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses.
Marzi A, Feldmann F, Geisbert TW, Feldmann H, Safronetz D. Marzi A, et al. Emerg Infect Dis. 2015 Feb;21(2):305-7. doi: 10.3201/eid2102.141649. Emerg Infect Dis. 2015. PMID: 25625358 Free PMC article.
Ebola virus: from discovery to vaccine.
Feldmann H, Jones S, Klenk HD, Schnittler HJ. Feldmann H, et al. Nat Rev Immunol. 2003 Aug;3(8):677-85. doi: 10.1038/nri1154. Nat Rev Immunol. 2003. PMID: 12974482 Review.
Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine.
Zhou Y, Sullivan NJ. Zhou Y, et al. Curr Opin Immunol. 2015 Aug;35:131-6. doi: 10.1016/j.coi.2015.06.006. Epub 2015 Aug 3. Curr Opin Immunol. 2015. PMID: 26247875 Review.

See all similar articles

Cited by

Clinical characteristics of 154 patients suspected of having Ebola virus disease in the Ebola holding center of Jui Government Hospital in Sierra Leone during the 2014 Ebola outbreak.
Yan T, Mu J, Qin E, Wang Y, Liu L, Wu D, Jia H, Li Z, Guo T, Wang X, Qin Y, Li Y, Chen S, Zhang Y, Zhang J, Wu Y, Wang S, Li J. Yan T, et al. Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):2089-95. doi: 10.1007/s10096-015-2457-z. Epub 2015 Jul 30. Eur J Clin Microbiol Infect Dis. 2015. PMID: 26223324
Understanding the dynamics of Ebola epidemics.
Legrand J, Grais RF, Boelle PY, Valleron AJ, Flahault A. Legrand J, et al. Epidemiol Infect. 2007 May;135(4):610-21. doi: 10.1017/S0950268806007217. Epub 2006 Sep 26. Epidemiol Infect. 2007. PMID: 16999875 Free PMC article. Clinical Trial.
Deadly viral syndrome mimics.
Lowenstein R. Lowenstein R. Emerg Med Clin North Am. 2004 Nov;22(4):1051-65, ix-x. doi: 10.1016/j.emc.2004.05.005. Emerg Med Clin North Am. 2004. PMID: 15474781 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information